文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

癌症相关成纤维细胞在胰腺癌中的多方面作用。

The multi-faceted roles of cancer-associated fibroblasts in pancreatic cancer.

作者信息

Kwon John Y, Vera Renzo E, Fernandez-Zapico Martin E

机构信息

Schulze Center for Novel Therapeutics, Division of Oncology Research, Rochester, MN 55901, USA.

出版信息

Cell Signal. 2025 Mar;127:111584. doi: 10.1016/j.cellsig.2024.111584. Epub 2025 Jan 3.


DOI:10.1016/j.cellsig.2024.111584
PMID:39756502
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11807759/
Abstract

The tumor microenvironment (TME) has been linked with the pathogenesis of pancreatic ductal adenocarcinoma (PDAC), the most common histological subtype of pancreatic cancer. A central component of the TME are cancer-associated fibroblasts (CAFs), which can either suppress or promote tumor growth in a context-dependent manner. In this review, we will discuss the multi-faceted roles of CAFs in tumor-stroma interactions influencing cancer initiation, progression and therapeutic response.

摘要

肿瘤微环境(TME)与胰腺癌最常见的组织学亚型——胰腺导管腺癌(PDAC)的发病机制相关。肿瘤微环境的一个核心组成部分是癌症相关成纤维细胞(CAFs),它们可以根据具体情况抑制或促进肿瘤生长。在这篇综述中,我们将讨论癌症相关成纤维细胞在影响癌症起始、进展和治疗反应的肿瘤-基质相互作用中的多方面作用。

相似文献

[1]
The multi-faceted roles of cancer-associated fibroblasts in pancreatic cancer.

Cell Signal. 2025-3

[2]
The function of microRNA related to cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.

Biochem Pharmacol. 2025-6

[3]
Depicting the cellular complexity of pancreatic adenocarcinoma by Imaging Mass Cytometry: focus on cancer-associated fibroblasts.

Front Immunol. 2024

[4]
Exploring the role of antigen-presenting cancer-associated fibroblasts and CD74 on the pancreatic ductal adenocarcinoma tumor microenvironment.

Med Oncol. 2024-11-25

[5]
GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells.

FASEB J. 2018-1-3

[6]
Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors.

Proc Natl Acad Sci U S A. 2018-1-19

[7]
Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts.

Cancer Genomics Proteomics. 2021

[8]
CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment.

J Exp Clin Cancer Res. 2024-10-3

[9]
Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma.

Cancer Med. 2017-2

[10]
CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.

FASEB J. 2020-7

本文引用的文献

[1]
Barriers and opportunities in pancreatic cancer immunotherapy.

NPJ Precis Oncol. 2024-9-12

[2]
Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions.

Commun Biol. 2024-4-9

[3]
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma.

Clin Cancer Res. 2024-5-1

[4]
Stiffness-induced cancer-associated fibroblasts are responsible for immunosuppression in a platelet-derived growth factor ligand-dependent manner.

PNAS Nexus. 2023-12-18

[5]
Inhibiting stromal Class I HDACs curbs pancreatic cancer progression.

Nat Commun. 2023-12-6

[6]
A Quick Guide to CAF Subtypes in Pancreatic Cancer.

Cancers (Basel). 2023-5-4

[7]
Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment.

Nat Commun. 2023-2-13

[8]
GLI1 interaction with p300 modulates SDF1 expression in cancer-associated fibroblasts to promote pancreatic cancer cells migration.

Biochem J. 2023-2-15

[9]
Development of Nectin4/FAP-targeted CAR-T cells secreting IL-7, CCL19, and IL-12 for malignant solid tumors.

Front Immunol. 2022

[10]
The difficulty in translating the preclinical success of combined TGFβ and immune checkpoint inhibition to clinical trial.

EBioMedicine. 2022-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索